Mucormycosis related cardiovascular changes study
Not Applicable
- Conditions
- Health Condition 1: B49- Unspecified mycosis
- Registration Number
- CTRI/2022/04/041778
- Lead Sponsor
- All India Institute of Medical Science Bathinda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
age greater than 18 years
nucor cases reporting to cardiology out patient department
valid informed consent
Exclusion Criteria
not giving consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total cardiovascular events in the groupTimepoint: 4 weeks after presentation
- Secondary Outcome Measures
Name Time Method Characterization of inflammation on cardio-vascular outcomesTimepoint: 30 days post hospital admission;Incidence of acute myocardial events in Mucormycosis population â?¨at baseline and during hospital stayTimepoint: 30 days;Myocarditis or myocardial infarction or stenosis detected with ST segment elevation or depression associated with troponin elevation and echocardiographyTimepoint: 30 days post hospital admission;New onset cardiac arrhythmiaTimepoint: 30 days post hospital admission